Brokers Set Expectations for Tivity Health Inc’s Q1 2017 Earnings (TVTY)
Tivity Health Inc (NASDAQ:TVTY) – Investment analysts at SunTrust Banks issued their Q1 2017 earnings estimates for Tivity Health in a report issued on Wednesday. SunTrust Banks analyst D. Macdonald forecasts that the brokerage will post earnings of $0.34 per share for the quarter. SunTrust Banks has a “Buy” rating and a $35.00 price target on the stock. SunTrust Banks also issued estimates for Tivity Health’s Q2 2017 earnings at $0.39 EPS, Q3 2017 earnings at $0.38 EPS, Q4 2017 earnings at $0.38 EPS, FY2017 earnings at $1.49 EPS, Q1 2018 earnings at $0.38 EPS, Q2 2018 earnings at $0.42 EPS, Q3 2018 earnings at $0.42 EPS, Q4 2018 earnings at $0.42 EPS, FY2018 earnings at $1.65 EPS and FY2019 earnings at $1.82 EPS.
TVTY has been the topic of several other research reports. Cantor Fitzgerald reissued a “buy” rating and issued a $32.00 price target on shares of Tivity Health in a research report on Friday, February 24th. Zacks Investment Research lowered shares of Tivity Health from a “buy” rating to a “hold” rating in a research report on Friday, January 27th. Oppenheimer Holdings Inc. set a $32.00 price target on shares of Tivity Health and gave the company a “buy” rating in a research report on Saturday, February 25th. Finally, Jefferies Group LLC reissued a “buy” rating and issued a $33.00 price target on shares of Tivity Health in a research report on Friday, February 24th. Two investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $29.06.
Your IP Address:
Shares of Tivity Health (NASDAQ:TVTY) opened at 28.75 on Monday. Tivity Health has a 12 month low of $9.53 and a 12 month high of $30.55. The firm’s market cap is $1.12 billion. The firm has a 50-day moving average of $27.24 and a 200-day moving average of $24.76.
Tivity Health (NASDAQ:TVTY) last issued its earnings results on Thursday, February 23rd. The company reported $0.35 earnings per share for the quarter, beating analysts’ consensus estimates of $0.30 by $0.05. Tivity Health had a negative net margin of 24.50% and a positive return on equity of 13.49%. The firm had revenue of $124.93 million for the quarter, compared to analyst estimates of $125.18 million. During the same quarter last year, the business posted $0.26 earnings per share. The company’s quarterly revenue was up 10.1% on a year-over-year basis.
In related news, insider Conan Laughlin sold 2,000,000 shares of the company’s stock in a transaction that occurred on Wednesday, March 1st. The shares were sold at an average price of $28.30, for a total transaction of $56,600,000.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Mary Jane England sold 2,340 shares of the company’s stock in a transaction that occurred on Friday, March 3rd. The stock was sold at an average price of $28.60, for a total transaction of $66,924.00. Following the sale, the director now directly owns 23,890 shares in the company, valued at approximately $683,254. The disclosure for this sale can be found here. Insiders have sold a total of 2,006,981 shares of company stock worth $56,778,263 in the last ninety days. 14.01% of the stock is currently owned by insiders.
Tivity Health Company Profile
Tivity Health, Inc, formerly Healthways, Inc, provides network delivered solutions and population health management services that are designed to help people manage their wellbeing, thereby managing their health and productivity, and their health-related costs. The Company operates in the domestic and international segments, which are collectively known as the well-being improvement services segment.
Receive News & Stock Ratings for Tivity Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health Inc and related stocks with our FREE daily email newsletter.